Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NRG1-ErbB4 signaling in the mPFC mediates adolescent social isolation-induced depressive-like behaviors.

Pharmacological research·2026
Same author

Synthesis of masked α,β-unsaturated trifluoromethyl ketones <i>via</i> iodine(III)-mediated double decarboxylative trifluoroacetylation.

Organic & biomolecular chemistry·2026
Same author

The Dual-Function of CtrNAC019-CtrNPF2.1 Module in Salt Tolerance and Nitrogen Use Efficiency Via Enhancing Vacuolar Chloride Sequestration and Nitrate Efflux in Citrus trifoliata.

Plant biotechnology journal·2026
Same author

TAF1 and GCN5-mediated histone acetylation of regulatory cascade AHL14/17-A/NINV7 promotes sucrose catabolism and sugar accumulation for cold tolerance in Citrus.

The New phytologist·2026
Same author

CsERF113 and CsERF7 antagonistically modulate citrus fruit abscission by regulating CsSAMDC1/2/3-mediated spermidine biosynthesis.

The New phytologist·2026
Same author

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.

Future oncology (London, England)·2026
Same journal

[Research progress on multimodal precision nursing interventions in urinary incontinence rehabilitation management after radical prostatectomy].

Zhonghua nan ke xue = National journal of andrology·2025
Same journal

[Dietary intervention to improve erectile dysfunction: Progress in research].

Zhonghua nan ke xue = National journal of andrology·2025
Same journal

[Tonifying kidney and activating blood therapy for the treatment of diabetic erectile dysfunction: A systematic review and meta-analysis].

Zhonghua nan ke xue = National journal of andrology·2025
Same journal

[Clinical effect of Huotujiji prescription on patients with asthenospermia of spleen-kidney yang-deficiency type].

Zhonghua nan ke xue = National journal of andrology·2025
Same journal

[Application of predictive nursing to the rehabilitation of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery].

Zhonghua nan ke xue = National journal of andrology·2025
Same journal

[Influencing factors of lower urinary tract symptoms in patients after radical prostatectomy and nursing strategy].

Zhonghua nan ke xue = National journal of andrology·2025
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

[Gene therapy for erectile dysfunction: an update].

Ji-hong Liu1, Ming-chao Li

  • 1Department of Urology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. jhliu@tjh.tjmu.edu.cn

Zhonghua Nan Ke Xue = National Journal of Andrology
|March 17, 2011
PubMed
Summary
This summary is machine-generated.

Gene therapy offers a promising new approach for treating erectile dysfunction (ED), especially when traditional treatments like PDE5 inhibitors are ineffective. This overview explores gene therapy

Related Experiment Videos

Last Updated: Jun 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

  • Urology
  • Regenerative Medicine
  • Molecular Biology

Context:

  • Erectile dysfunction (ED) affects millions globally, with increasing prevalence in aging populations and those with chronic conditions like diabetes.
  • Current treatments, primarily phosphodiesterase type 5 (PDE5) inhibitors, have limitations, particularly for complex ED cases.
  • Understanding the pathogenesis of ED has advanced significantly, paving the way for novel therapeutic strategies.

Purpose:

  • To provide a comprehensive overview of the advancements in gene therapy for managing erectile dysfunction.
  • To highlight the potential of gene therapy as an alternative treatment for ED unresponsive to conventional therapies.
  • To review gene therapy's application in ED linked to specific conditions such as diabetes, aging, nerve injury, and vascular damage.

Summary:

  • Gene therapy is emerging as a viable therapeutic option for erectile dysfunction (ED), offering a potential solution where PDE5 inhibitors fall short.
  • Recent progress in gene therapy research demonstrates its efficacy in preclinical models for ED associated with diabetes, aging, nerve injury, and vascular lesions.
  • This review synthesizes current knowledge on gene therapy strategies for ED, focusing on mechanisms and clinical potential.

Impact:

  • Gene therapy holds the potential to revolutionize ED treatment, offering targeted and potentially curative solutions for a significant unmet medical need.
  • Successful gene therapy approaches could restore erectile function in patients with severe or complex forms of ED, improving quality of life.
  • Further research and clinical translation of gene therapy could lead to new standards of care for male sexual health.